These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo. Kumar N; Taily IM; Singh C; Kumar S; Rajmani RS; Chakraborty D; Sharma A; Singh P; Thakur KG; Varadarajan R; Ringe RP; Banerjee P; Banerjee I PLoS Pathog; 2023 May; 19(5):e1011358. PubMed ID: 37126530 [TBL] [Abstract][Full Text] [Related]
6. Broad-Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity. Zelikin AN; Stellacci F Adv Healthc Mater; 2021 Mar; 10(6):e2001433. PubMed ID: 33491915 [TBL] [Abstract][Full Text] [Related]
7. Broad-spectrum antiviral activity of Spatholobus suberectus Dunn against SARS-CoV-2, SARS-CoV-1, H5N1, and other enveloped viruses. Liu Q; Kwan KY; Cao T; Yan B; Ganesan K; Jia L; Zhang F; Lim C; Wu Y; Feng Y; Chen Z; Liu L; Chen J Phytother Res; 2022 Aug; 36(8):3232-3247. PubMed ID: 35943221 [TBL] [Abstract][Full Text] [Related]
8. Fusion Protein Targeted Antiviral Peptides: Fragment-Based Drug Design (FBDD) Guided Rational Design of Dipeptides Against SARS-CoV-2. Manna S; Chowdhury T; Baindara P; Mandal SM Curr Protein Pept Sci; 2020; 21(10):938-947. PubMed ID: 32901582 [TBL] [Abstract][Full Text] [Related]
9. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351). Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968 [TBL] [Abstract][Full Text] [Related]
10. Inhibitors of Anti-apoptotic Bcl-2 Family Proteins Exhibit Potent and Broad-Spectrum Anti-mammarenavirus Activity via Cell Cycle Arrest at G0/G1 Phase. Kim YJ; Witwit H; Cubitt B; de la Torre JC J Virol; 2021 Nov; 95(24):e0139921. PubMed ID: 34586865 [TBL] [Abstract][Full Text] [Related]
11. Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication. Tripp RA; Martin DE Viruses; 2022 Mar; 14(3):. PubMed ID: 35337018 [TBL] [Abstract][Full Text] [Related]
12. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies. Seyedpour S; Khodaei B; Loghman AH; Seyedpour N; Kisomi MF; Balibegloo M; Nezamabadi SS; Gholami B; Saghazadeh A; Rezaei N J Cell Physiol; 2021 Apr; 236(4):2364-2392. PubMed ID: 32901936 [TBL] [Abstract][Full Text] [Related]
13. The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction. Joseph J; Karthika T; Das VRA; Raj VS Curr Pharm Biotechnol; 2022; 23(8):1118-1129. PubMed ID: 34375189 [TBL] [Abstract][Full Text] [Related]
15. The Analogs of Furanyl Methylidene Rhodanine Exhibit Broad-Spectrum Inhibitory and Inactivating Activities against Enveloped Viruses, including SARS-CoV-2 and Its Variants. Pu J; He X; Xu W; Wang C; Lan Q; Hua C; Wang K; Lu L; Jiang S Viruses; 2022 Feb; 14(3):. PubMed ID: 35336896 [TBL] [Abstract][Full Text] [Related]
16. A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses. Meunier T; Desmarets L; Bordage S; Bamba M; Hervouet K; Rouillé Y; François N; Decossas M; Sencio V; Trottein F; Tra Bi FH; Lambert O; Dubuisson J; Belouzard S; Sahpaz S; Séron K Antimicrob Agents Chemother; 2022 Feb; 66(2):e0158121. PubMed ID: 34807755 [TBL] [Abstract][Full Text] [Related]
17. Molnupiravir and Its Antiviral Activity Against COVID-19. Tian L; Pang Z; Li M; Lou F; An X; Zhu S; Song L; Tong Y; Fan H; Fan J Front Immunol; 2022; 13():855496. PubMed ID: 35444647 [TBL] [Abstract][Full Text] [Related]
18. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin. Du X; Zuo X; Meng F; Han C; Ouyang W; Han Y; Gu Y; Zhao X; Xu F; Qin FX Cell Prolif; 2021 Jan; 54(1):e12953. PubMed ID: 33211371 [TBL] [Abstract][Full Text] [Related]
19. Potential inhibitors of SARS-CoV-2: recent advances. Jamalipour Soufi G; Iravani S J Drug Target; 2021 Apr; 29(4):349-364. PubMed ID: 33210953 [TBL] [Abstract][Full Text] [Related]
20. The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation. Shilagardi K; Spear ED; Abraham R; Griffin DE; Michaelis S mBio; 2022 Oct; 13(5):e0254322. PubMed ID: 36197088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]